Journals / Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi / 2017 / Cilt: 63 - Sayı: 3

Inflammatory arthritis complicated by inflammatory bowel disease: two case reports

Pages
266–271
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In the event of complaints related to the gastrointestinal tract in patients with PsA or RA, IBD should be kept in mind, and the clinical evaluation and multidisciplinary interventions should be planned to control the underlying autoimmune process

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Coexistence of inflammatory arthritis disease and inflammatory bowel disease (IBD) is often considered to be relatively rare, and the underlying mechanisms of the association between them remain unclear.
📊
Key Findings & Data:Herein, we report two cases of IBD which occurred during the course of inflammatory arthritis disease.
💡
Conclusion & Impact:In the event of complaints related to the gastrointestinal tract in patients with PsA or RA, IBD should be kept in mind, and the clinical evaluation and multidisciplinary interventions should be planned to control the underlying autoimmune process
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Coexistence of inflammatory arthritis disease and inflammatory bowel disease (IBD) is often considered to be relatively rare, and the underlying mechanisms of the association between them remain unclear. Herein, we report two cases of IBD which occurred during the course of inflammatory arthritis disease. The first case had psoriatic arthritis (PsA) for two and a half years complicated by Crohn’s disease and accompanied by inactive carrier state of hepatitis B. The second case had rheumatoid arthritis (RA) complicated by ulcerative colitis four years after the onset of RA. In both cases, colonoscopy was performed, and their clinical presentations improved with a multidisciplinary approach. In the event of complaints related to the gastrointestinal tract in patients with PsA or RA, IBD should be kept in mind, and the clinical evaluation and multidisciplinary interventions should be planned to control the underlying autoimmune process

🔖

Cite This Article

UMAY, E., KARAAHMET, F., KARAAHMET, Ö. Z., ÇAKCI, A., CENGİZ, D., GÜRÇAY, E. (2022). Inflammatory arthritis complicated by inflammatory bowel disease: two case reports. Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi, Cilt: 63 - Sayı: 3, 266–271. https://ajindex.com/articles/628588

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Baumgart DC, Sandborn WJ. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 2007;369:1641-57
  2. Pithadia AB, Jain S. Treatment of inflammatory bowel disease (IBD). Pharmacol Rep 2011;63:629-42
  3. Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012;142:46-54
  4. Cohen AD, Dreiher J, Birkenfeld S. Psoriasis associated with ulcerative colitis and Crohn’s disease. J Eur Acad Dermatol Venereol 2009;23:561-5
  5. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998;115:182-205
  6. Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med 2009;361:2066-78
  7. Cohen R, Robinson D Jr, Paramore C, Fraeman K, Renahan K, Bala M. Autoimmune disease concomitance among inflammatory bowel disease patients in the United States, 2001-2002. Inflamm Bowel Dis 2008;14:738-43
  8. Bernstein CN, Wajda A, Blanchard JF. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. Gastroenterology 2005;129:827-36
  9. Vilela EG, Torres HO, Martins FP, Ferrari Mde L, Andrade MM, Cunha AS. Evaluation of inflammatory activity in Crohn’s disease and ulcerative colitis. World J Gastroenterol 2012;18:872-81
  10. Stange EF, Travis SP, Vermeire S, Beglinger C, Kupcinkas L, Geboes K, et al. European evidence based consensus on the diagnosis and management of Crohn’s disease: definitions and diagnosis. Gut 2006;55:1-15
  11. Seo M, Okada M, Yao T, Okabe N, Maeda K, Oh K. Evaluation of disease activity in patients with moderately active ulcerative colitis: comparisons between a new activity index and Truelove and Witts’ classification. Am J Gastroenterol 1995;90:1759-63
  12. Sugisaki K, Honma F, Iwadate H, Shio K, Shioya Y, Fukaya E, et al. Ulcerative colitis occurring in the course of rheumatoid arthritis: a case successfully treated with mesalamine enema. Intern Med 2004;43:1046-50
  13. Ho P, Bruce IN, Silman A, Symmons D, Newman B, Young H, et al. Evidence for common genetic control in pathways of inflammation for Crohn’s disease and psoriatic arthritis. Arthritis Rheum 2005;52:3596-602
  14. Rahman P, Bartlett S, Siannis F, Pellett FJ, Farewell VT, Peddle L, et al. CARD15: a pleiotropic autoimmune gene that confers susceptibility to psoriatic arthritis. Am J H